vTv Therapeutics (VTVT) Amortizatization of Intangibles (2017 - 2020)
vTv Therapeutics (VTVT) reported Amortizatization of Intangibles of $40000.0 for Q4 2020, down 51.22% on a YoY basis from $82000.0 in Q1 2020, and down 74.68% sequentially from $158000.0 in Q3 2020.
vTv Therapeutics (VTVT) Amortizatization of Intangibles (2017 - 2020) Analysis & Trends
vTv Therapeutics (VTVT) has 4 years of Amortizatization of Intangibles data on file, last reported at $40000.0 in Q4 2020.
- For the quarter ending Q4 2020, Amortizatization of Intangibles fell 51.22% year-over-year to $40000.0; the trailing twelve-month figure through Dec 2020 stood at $380000.0 (down 28.57% YoY), and the FY2020 full-year result was $380000.0, down 28.57% from the prior year.
- Amortizatization of Intangibles eased to $40000.0 in Q4 2020, from $158000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $276000.0 in Q2 2017 to a low of $40000.0 in Q4 2020.
- A 4-year average of $184687.5 and a median of $194000.0 in 2017 frame the typical range for Amortizatization of Intangibles.
- Peak annual rise in Amortizatization of Intangibles reached 37.39% in 2020, while the deepest fall reached 74.59% in 2020.
- Tracing VTVT's Amortizatization of Intangibles over 4 years: stood at $276000.0 in 2017, then slipped by 20.65% to $219000.0 in 2018, then tumbled by 62.56% to $82000.0 in 2019, then tumbled by 51.22% to $40000.0 in 2020.
- Business Quant data shows VTVT's Amortizatization of Intangibles at $40000.0 in Q4 2020, $158000.0 in Q3 2020, and $135000.0 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 40,000.00 |
| Dec 31, 2020 | 40,000.00 |
| Sep 30, 2020 | 158,000.00 |
| Sep 30, 2020 | 158,000.00 |
| Jun 30, 2020 | 135,000.00 |
| Jun 30, 2020 | 135,000.00 |
| Mar 31, 2020 | 47,000.00 |
| Mar 31, 2020 | 47,000.00 |
| Dec 31, 2019 | 82,000.00 |
| Dec 31, 2019 | 82,000.00 |
| Sep 30, 2019 | 115,000.00 |
| Sep 30, 2019 | 115,000.00 |
| Jun 30, 2019 | 150,000.00 |
| Jun 30, 2019 | 150,000.00 |
| Mar 31, 2019 | 185,000.00 |
| Mar 31, 2019 | 185,000.00 |
| Dec 31, 2018 | 219,000.00 |
| Dec 31, 2018 | 219,000.00 |
| Sep 30, 2018 | 248,000.00 |
| Sep 30, 2018 | 248,000.00 |